(AI) Air Liquide - Ratings and Ratios
Oxygen, Nitrogen, Argon, Hydrogen, Carbon Monoxide
Description: AI Air Liquide
Air Liquide SA is a global leader in providing gases, technologies, and services to industrial and healthcare sectors across multiple regions, including Europe, the Americas, Asia Pacific, the Middle East, and Africa. The companys diversified business segments, including Gas & Services, Engineering & Construction, and Global Markets & Technologies, enable it to cater to a broad range of industries, from energy and chemicals to healthcare and electronics.
The Gas & Services segment is a significant contributor, offering a range of products and services, including industrial gases, medical gases, and energy solutions. The companys industrial merchant business line serves various sectors, including materials and energy, automotive, and pharmaceuticals. Additionally, the healthcare business provides medical gases, home healthcare services, and medical equipment to patients and healthcare professionals.
Air Liquides Engineering & Construction segment designs and builds industrial gas production plants, as well as plants for traditional, renewable, and alternative energy sectors. The Global Markets & Technologies segment focuses on delivering technological solutions for energy transition and deep technology, including biomethane production units and hydrogen refueling stations.
From a financial perspective, Air Liquide has a market capitalization of over 101 billion EUR, with a forward P/E ratio of 25.64, indicating a relatively stable valuation. The companys return on equity (RoE) stands at 13.34%, suggesting a decent level of profitability. Key performance indicators (KPIs) to monitor include revenue growth, EBITDA margins, and cash flow generation, which can provide insights into the companys operational efficiency and ability to invest in new technologies and growth initiatives.
Some additional KPIs to consider when evaluating Air Liquides performance include its debt-to-equity ratio, interest coverage ratio, and dividend yield. The companys ability to maintain a stable dividend payout and invest in growth initiatives will be crucial in driving long-term shareholder value. Furthermore, Air Liquides exposure to various industries and geographies can provide a natural hedge against economic downturns, making it a relatively stable investment opportunity.
AI Stock Overview
| Market Cap in USD | 120,265m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
AI Stock Ratings
| Growth Rating | 67.5% |
| Fundamental | 61.6% |
| Dividend Rating | 58.2% |
| Return 12m vs S&P 500 | -8.22% |
| Analyst Rating | - |
AI Dividends
| Dividend Yield 12m | 1.89% |
| Yield on Cost 5y | 3.15% |
| Annual Growth 5y | 5.45% |
| Payout Consistency | 99.3% |
| Payout Ratio | 55.7% |
AI Growth Ratios
| Growth Correlation 3m | -31.5% |
| Growth Correlation 12m | 70.7% |
| Growth Correlation 5y | 94.3% |
| CAGR 5y | 10.88% |
| CAGR/Max DD 5y | 0.47 |
| Sharpe Ratio 12m | 0.25 |
| Alpha | 0.05 |
| Beta | 0.185 |
| Volatility | 20.93% |
| Current Volume | 392.9k |
| Average Volume 20d | 443.2k |
| Stop Loss | 172 (-3%) |
| Signal | -1.78 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (5.11b TTM) > 0 and > 6% of Revenue (6% = 2.45b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.67% (prev -4.27%; Δ 0.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 9.18b > Net Income 5.11b (YES >=105%, WARN >=100%) |
| Net Debt (10.53b) to EBITDA (7.47b) ratio: 1.41 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (576.7m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 63.13% (prev 59.62%; Δ 3.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 83.51% (prev 57.12%; Δ 26.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 12.33 (EBITDA TTM 7.47b / Interest Expense TTM 426.9m) >= 6 (WARN >= 3) |
Altman Z'' 2.77
| (A) -0.03 = (Total Current Assets 8.04b - Total Current Liabilities 9.54b) / Total Assets 49.34b |
| (B) 0.39 = Retained Earnings (Balance) 19.48b / Total Assets 49.34b |
| (C) 0.11 = EBIT TTM 5.26b / Avg Total Assets 48.83b |
| (D) 0.91 = Book Value of Equity 22.66b / Total Liabilities 24.82b |
| Total Rating: 2.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.58
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 2.39% = 1.19 |
| 3. FCF Margin 6.56% = 1.64 |
| 4. Debt/Equity 0.43 = 2.41 |
| 5. Debt/Ebitda 1.41 = 1.12 |
| 6. ROIC - WACC 4.52% = 5.65 |
| 7. RoE 20.35% = 1.70 |
| 8. Rev. Trend -62.72% = -3.14 |
| 9. Rev. CAGR -1.25% = -0.21 |
| 10. EPS Trend 8.53% = 0.21 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of AI shares?
Over the past week, the price has changed by -3.22%, over one month by +2.90%, over three months by -2.86% and over the past year by +8.01%.
Is Air Liquide a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AI is around 181.01 EUR . This means that AI is currently overvalued and has a potential downside of 2.03%.
Is AI a buy, sell or hold?
What are the forecasts/targets for the AI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 196.6 | 10.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 197.7 | 11.4% |
AI Fundamental Data Overview
Market Cap EUR = 103.25b (103.25b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 1.64b EUR (last quarter)
P/E Trailing = 29.7909
P/E Forward = 26.9542
P/S = 3.768
P/B = 4.2502
P/EG = 2.2456
Beta = 0.695
Revenue TTM = 40.78b EUR
EBIT TTM = 5.26b EUR
EBITDA TTM = 7.47b EUR
Long Term Debt = 8.61b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.89b EUR (from shortTermDebt, last quarter)
Debt = 10.50b EUR (Calculated: Short Term 1.89b + Long Term 8.61b)
Net Debt = 10.53b EUR (from netDebt column, last fiscal year)
Enterprise Value = 112.10b EUR (103.25b + Debt 10.50b - CCE 1.64b)
Interest Coverage Ratio = 12.33 (Ebit TTM 5.26b / Interest Expense TTM 426.9m)
FCF Yield = 2.39% (FCF TTM 2.67b / Enterprise Value 112.10b)
FCF Margin = 6.56% (FCF TTM 2.67b / Revenue TTM 40.78b)
Net Margin = 12.52% (Net Income TTM 5.11b / Revenue TTM 40.78b)
Gross Margin = 63.13% ((Revenue TTM 40.78b - Cost of Revenue TTM 15.04b) / Revenue TTM)
Tobins Q-Ratio = 4.95 (Enterprise Value 112.10b / Book Value Of Equity 22.66b)
Interest Expense / Debt = 1.97% (Interest Expense 207.0m / Debt 10.50b)
Taxrate = 24.00% (from yearly Income Tax Expense: 1.09b / 4.53b)
NOPAT = 4.00b (EBIT 5.26b * (1 - 24.00%))
Current Ratio = 0.84 (Total Current Assets 8.04b / Total Current Liabilities 9.54b)
Debt / Equity = 0.43 (Debt 10.50b / last Quarter total Stockholder Equity 24.51b)
Debt / EBITDA = 1.41 (Net Debt 10.53b / EBITDA 7.47b)
Debt / FCF = 3.93 (Debt 10.50b / FCF TTM 2.67b)
Total Stockholder Equity = 25.10b (last 4 quarters mean)
RoA = 10.35% (Net Income 5.11b, Total Assets 49.34b )
RoE = 20.35% (Net Income TTM 5.11b / Total Stockholder Equity 25.10b)
RoCE = 15.61% (Ebit 5.26b / (Equity 25.10b + L.T.Debt 8.61b))
RoIC = 10.74% (NOPAT 4.00b / Invested Capital 37.25b)
WACC = 6.22% (E(103.25b)/V(113.75b) * Re(6.70%)) + (D(10.50b)/V(113.75b) * Rd(1.97%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 80.0 | Cagr: 2.55%
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.81% ; FCFE base≈2.72b ; Y1≈2.64b ; Y5≈2.62b
Fair Price DCF = 80.94 (DCF Value 46.68b / Shares Outstanding 576.7m; 5y FCF grow -4.36% → 3.0% )
Revenue Correlation: -62.72 | Revenue CAGR: -1.25%
Rev Growth-of-Growth: 6.35
EPS Correlation: 8.53 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 9.59